Innoviva, Inc.INVANASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank59
5Y CAGR+36.5%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
+36.5%/yr
Long-term compound
Percentile
P59
Within normal range
vs 5Y Ago
4.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 20259.50%
Q3 20257.50%
Q2 202513.15%
Q1 2025-3.46%
Q4 20242.57%
Q3 2024-13.40%
Q2 202433.36%
Q1 2024-9.72%
Q4 202327.63%
Q3 2023-16.96%
Q2 20236.05%
Q1 202316.06%
Q4 2022-2.16%
Q3 2022-37.85%
Q2 202220.17%
Q1 2022-16.36%
Q4 202110.03%
Q3 2021-2.92%
Q2 202117.88%
Q1 2021-5.48%
Q4 20202.01%
Q3 202012.35%
Q2 20200.34%
Q1 20203.56%
Q4 201915.54%
Q3 20192.57%
Q2 201916.17%
Q1 2019-30.90%
Q4 201829.47%
Q3 2018-8.06%
Q2 201828.08%
Q1 2018-24.65%
Q4 201742.92%
Q3 2017-16.94%
Q2 201744.63%
Q1 2017-7.15%
Q4 201630.93%
Q3 20162.58%
Q2 201634.32%
Q1 20165.87%